P, M., NL, M., JT, R., R, P., S, R., SW, T., . . . JG, R. (2023). Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition. Clinical pharmacology and therapeutics, 114(2), 423. https://doi.org/10.1002/cpt.2958
Chicago Style (17th ed.) CitationP, Mallaroni, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KPC, and Ramaekers JG. "Assessment of the Acute Effects of 2C-B Vs. Psilocybin on Subjective Experience, Mood, and Cognition." Clinical Pharmacology and Therapeutics 114, no. 2 (2023): 423. https://doi.org/10.1002/cpt.2958.
MLA (9th ed.) CitationP, Mallaroni, et al. "Assessment of the Acute Effects of 2C-B Vs. Psilocybin on Subjective Experience, Mood, and Cognition." Clinical Pharmacology and Therapeutics, vol. 114, no. 2, 2023, p. 423, https://doi.org/10.1002/cpt.2958.